Pfizer to sell remaining stake in Haleon

 

• Pfizer (NYSE:PFE) is planning to sell 662M shares of Haleon (NYSE:HLN) to divest its remaining stake in the U.K.-based consumer healthcare company, Bloomberg News reported Tuesday, citing Citigroup (C) which serves as a joint global coordinator and bookrunner for the sale.
• The sale, representing about a 7.3% stake in the Sensodyne toothpaste maker, is expected to start shortly, and the company is planning to conduct an accelerated book-building process to determine the price. 
• The New York-based pharma giant joined GSK (GSK) in founding Haleon (NYSE:HLN) in 2019. Since Haleon (NYSE:HLN) completed its spinoff from GSK in 2022, its founders have been reducing their ownership stakes.
• While the British pharmaceutical giant completed its divestment in May, PFE sold about 700M shares of the company in January, reducing its stake from about 15.0% to 7.3%. 

https://www.msn.com/en-us/money/companies/pfizer-to-sell-remaining-stake-in-haleon/ar-AA1BbgpM?ocid=finance-verthp-feeds